Actively Recruiting
Evaluating New Diagnostic Methods Using TINY Device for Lymphoma and Multicentric Castleman Disease Detection in HIV-Infected Patients
Led by Indiana University · Updated on 2026-08-28
500
Participants Needed
1
Research Sites
N/A
Total Duration
AI-Summary
What This Trial Is About
This research focuses on people living with HIV in sub-Saharan Africa who have unexplained lymphadenopathy, a swollen lymph node condition that may indicate serious diseases like tuberculosis, lymphoma, or multicentric Castleman disease MCD. The study aims to develop and evaluate new diagnostic methods to better identify lymphoma and MCD, addressing delays and missed diagnoses that currently occur in this population. It specifically investigates the use of a novel nucleic acid measurement assay to detect viruses linked to these diseases. The study uses an innovative device called the Tiny Isothermal Nucleic acid Amplification System TINY to analyze samples from fine needle aspirations and biopsies. This device measures nucleic acids related to Epstein-Barr virus EBV and Kaposi sarcoma herpesvirus KSHV, which are important markers for lymphoma and MCD. Participants are HIV-infected patients with unexplained lymphadenopathy, and their samples will undergo testing by TINY and other methods like Gene Xpert and quantitative PCR. Participants will be involved in providing samples through fine needle aspiration or lymph nodecore needle biopsy. Researchers will collect clinical and laboratory data at enrollment, evaluating the diagnostic performance of the TINY device for detecting EBV and KSHV DNA. The main outcome is the number of patients diagnosed using these new approaches. The study will continue until December 2028, with ongoing assessments during enrollment to monitor results and safety.
CONDITIONS
Brief Title
New Approaches for the Diagnosis of Lymphoma and Multicentric Castleman Disease
Research Team
M
Matthew Painschab, MD
Y
Yuri Fedoriw, MD
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here